Medicaid Just Decided How Long You Have to Stay Sober Before It Trusts You

In April, a Yale addiction-medicine fellow named John Fomeche sat across from a patient he’d watched build years of steady ground — consistent appointments, clean screens, a job, a kid she picked up from school every afternoon. She hadn’t come in that week to talk about a craving or a close call. She came in to tell him her insurance premium was jumping from $40 a month to $138. Fomeche wrote in STAT News that her voice changed in a way it hadn’t when they’d discussed the worst years of her using. “That number may not register as catastrophic to policymakers or insurers,” he wrote. “But to someone living paycheck to paycheck, it is not an ‘adjustment.’ It is a threat.”

Three months later, that threat has a name, a start date, and a paperwork trail attached to it.

The government just decided some kinds of recovery don’t count as real yet — and if you’ve been stable for less than five years, the burden is now on you to prove it, in writing, before it keeps paying for your care.

That’s the practical effect of CMS’s new Medicaid “community engagement” rule, an interim final regulation published in the Federal Register on June 3 that requires most Medicaid expansion adults, ages 19 to 64, to log 80 hours a month of work, school, or community service to keep their coverage. States have until January 1, 2027 to implement it. If you’re in active treatment, on paper, you’re exempt — the rule specifically lists “participants in a drug or alcohol rehabilitation or treatment program.” The part that should worry anyone further down the recovery road is the other exemption: “medically frail” status, for anyone whose condition “significantly impairs” their ability to work. CMS never defines that threshold in the rule itself. Advocates who’ve read the fine print say the agency has, elsewhere in its guidance, drawn a line at five years of “stable recovery” — after which the exemption runs out and you’re expected to prove, through a state reporting system, that you’re clocking your hours like anyone else.

The five-year line comes from studies that never met the people it now governs

Deborah Steinberg, a senior health policy attorney at the Legal Action Center writing for Georgetown University’s Center for Children and Families, has done the closest reading of this rule of anyone publishing so far. She counts three hurdles CMS built into the exemption process that don’t appear in the underlying statute Congress passed: a requirement to document “significant impairment” rather than simply a diagnosis, an exclusion for anyone in “stable recovery” of five years or more, and new limits on the kind of self-attestation Medicaid has relied on for years. That last point matters more than it sounds. Existing federal Medicaid regulation — 42 C.F.R. § 435.945(a) — already lets people self-attest to a condition without submitting a stack of records. This rule quietly narrows that, for this population, without Congress ever voting on the change.

The five-year number itself is the part that should make a clinician’s stomach drop. Steinberg traces it to abstinence studies conducted between 1989 and 2007 — samples that were predominantly male and, by three decades’ distance, look nothing like the Medicaid population applying this rule to today. Translated out of policy language: the government picked a number from research done on a different group of people, in a different era of the overdose crisis, before fentanyl, before telehealth buprenorphine, before most of the medications currently keeping people alive existed — and is now using that number to decide who still needs to prove they’re sick enough to skip a work-reporting requirement. Thirty percent of Medicaid expansion adults have a substance use disorder or mental health condition, per Steinberg’s count, and by her citation, fewer than one in five people who need SUD treatment currently receive it. This rule adds a new administrative filter in front of the one insurance line most of them are relying on to get it.

This rule adds a new administrative filter in front of the one insurance line most of them are relying on to get it.

If you’ve been in recovery long enough that the drama has mostly gone out of it — the appointments are routine, the milestones stopped feeling urgent, life just goes on now — this is aimed at you specifically. The rule doesn’t distinguish between someone six weeks out of detox and someone six years into a stable, unremarkable life. It just checks whether you’ve crossed the five-year mark, and if you have, the state now wants documentation that your recovery still “significantly impairs” you before it’ll keep treating you as exempt. Being fine is not, under this rule, actually a reason to stop proving you’re not fine enough to work.

Nebraska went first, and the math didn’t hold up

Nebraska didn’t wait for the January 2027 deadline. The state rolled out its version of the requirement on May 1, 2026, eight months ahead of the federal schedule, becoming the live test case for what this looks like in practice. The Urban Institute’s estimate: roughly 25,000 of the 72,000 Nebraskans the rule applies to could lose coverage — not because they don’t qualify for an exemption, but because of the reporting itself. Anthony Wright, executive director of Families USA, put it bluntly: “Eighteen months to implement such a massive undertaking of all these new eligibility and requirements is bad enough, but it’s even worse that for no reason at all, Nebraska has decided to start this process eight months early.” Sarah Maresh of Nebraska Appleseed named the actual failure mode: “A vast majority of Nebraskans are working, or would be an exemption, but it is the red tape. That’s what causes the problems.” Dr. Adam Gaffney, a critical-care physician at Harvard Medical School, framed the stakes for anyone managing a chronic condition through this system: “It is not easy being sick, and it’s especially hard to navigate bureaucracies and document exemptions like chronic illness.”

Nebraska’s own list of medical conditions that might qualify someone for an exemption runs close to 300 pages. Three hundred pages is not a document a case manager flips through during a fifteen-minute intake slot, and it is definitely not a document most people renewing their own coverage from a phone at work will read cover to cover before a deadline. That gap — between what the rule technically allows and what a person can actually navigate in time — is where coverage gets lost. It got lost that way once already.

We have watched a five-year-old version of this exact fight before, and it didn’t end well for the government. In 2018, Arkansas ran the first Medicaid work-requirement experiment in the country — adults 19 to 49, 80 hours a month, an SUD-treatment exemption built into the design from day one, on paper the same safeguard this rule claims to offer now. More than 16,900 people lost coverage anyway, almost entirely from failure to complete the reporting, not because they were found ineligible. In March 2019, Judge James Boasberg ruled that HHS had acted “arbitrarily and capriciously” in approving the program, finding the agency had never adequately weighed coverage loss against Medicaid’s core purpose of providing medical assistance. The D.C. Circuit affirmed that ruling the following year in Gresham v. Azar. The courts didn’t strike Arkansas down because the political climate turned — they struck it down because the process itself couldn’t distinguish a person who no longer needed the exemption from a person who simply couldn’t complete the paperwork on time. Nebraska is now running a program built on the same reporting architecture, at a larger scale, with a documentation bar that’s arguably higher.

The same spring, SAMHSA started asking why you’re still on methadone

The Medicaid rule didn’t land in isolation. On April 24, SAMHSA sent a “Dear Colleague” letter to clinicians reframing methadone and buprenorphine — the two medications with the strongest evidence base for keeping people with opioid use disorder alive — as things to actively “consider tapering,” rather than treatments a person might reasonably stay on for years. Writing in Filter, Helen Redmond talked to people who felt that shift land in the exam room before the letter was ever public. Jerry Otero, who manages the Drug User Health Hub at St. Ann’s Corner of Harm Reduction in the Bronx and is himself on methadone, described the pressure running the opposite direction from what the letter claims to be correcting: “My experience is that they are more inclined to push patients up, not to get off or taper down.” Bill Kinkle, a registered nurse and former methadone patient, remembered it from the other side of the counter: “There was major pressure to stay on indefinitely.” Redmond’s piece cites the number that should anchor this entire argument — methadone reduces overdose death rates by roughly 50 percent. A federal agency spending April nudging clinicians toward tapering the medication with the best mortality data we have is not a subtle signal.

A federal agency spending April nudging clinicians toward tapering the medication with the best mortality data we have is not a subtle signal.

It’s also not the only signal from the same building that month. STAT News reported that the same wave of April guidance discouraged federal dollars from funding fentanyl and xylazine test strips, sterile injection supplies, overdose hotlines, and medication-only opioid treatment that isn’t paired with counseling — alongside a SAMHSA workforce cut from roughly 900 staff to under half that number. None of these are the same policy as the Medicaid rule. But read together, they describe one federal posture: narrower eligibility for who still “needs” coverage, pressure to taper off the medications that work best, and less money for the cheap tools — a test strip costs about a dollar — that catch what medication alone doesn’t. Faces & Voices of Recovery, the national recovery-advocacy organization, flagged one more piece worth a sentence here: a separate CMS proposal, moving through the same process, that would cap Medicaid reimbursement for SUD services at Medicare rates — a cut advocates warn could push already-underpaid Medicaid treatment providers further underwater, right as the rest of this is landing.

What’s still yours, and what to do about the part that isn’t

Here’s what hasn’t changed, and it’s worth saying plainly before anything else: if you are actively in a rehab or treatment program right now, that exemption is written into the rule and it is not going away in this comment period. Naloxone access is not part of this fight. Methadone and buprenorphine have not been banned, tapered by force, or made harder to prescribe — SAMHSA sent a letter, not a rule, and it can be argued with in the same rooms where treatment decisions get made. If you’re a case manager, the concrete thing to do this week is smaller than it sounds: pull the list of clients you know are past the five-year mark on stable recovery and are covered through Medicaid expansion, and start the documentation conversation with them now, before their next renewal window, not after a denial letter arrives. The public comment period on the interim final rule runs through July 31 — for anyone who works with this population and has a case example the rule doesn’t account for, that window is still open.

Jerry Otero has been on methadone long enough to have opinions about being pushed off it. The patient in John Fomeche’s office is still showing up, still parenting, still working, and now doing the math on $138 a month against everything else that number could have paid for. Neither of them asked to become a test case for how long “recovered” is allowed to last before the government wants it re-proven. But that’s what a five-year cutoff drawn from a 1990s study does to someone with six years of quiet, uneventful stability: it turns the best evidence of their recovery — that nothing dramatic has happened in a long time — into the reason they now have to prove it happened at all.